Real‐World Evidence of Long‐Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three Years
Dulaglutide provided durable improvements in glycemic control and weight reduction for more than 3 years, even in patients with long-standing T2DM and comorbidities. These results support its role as a long-term treatment option in real-world clinical practice.
Authors
- Woo Je Lee (ORCID: https://orcid.org/0000-0002-9605-9693)
- Myeong‐Jin Kim (ORCID: https://orcid.org/0000-0001-7949-5402)
- Hwi Seung Kim (ORCID: https://orcid.org/0000-0001-5113-9895)
- Yun Kyung Cho (ORCID: https://orcid.org/0000-0002-4089-1376)
- Chang Hee Jung (ORCID: https://orcid.org/0000-0003-4043-2396)
- Hee Sung Kim (ORCID: https://orcid.org/0000-0003-2351-4402)
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- Sacred Heart Hospital (NG)
- Sacred Heart Hospital (US)
- Sacred Heart Hospital (US)
- Chung-Ang University Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
- Chung-Ang University (KR)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1111/cen.70078
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00